Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $77.1400 (-4.22%) ($76.6801 - $80.1000) on Mon. Jan. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 25 | Latest Price | $77.1400(-4.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -2.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) VYM(50%) DIA(49%) IVE(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -1.16% in a week (0% probabilities). TLT(-14%) VXX(-12%) UUP(-12%) VIXM(-11%) IFRA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
Resistance Level | $86.67 | 5 Day Moving Average | $84.13(-8.31%) | 10 Day Moving Average | $85.21(-9.47%) | 20 Day Moving Average | $86.67(-11%) | To recent high | -17.2% | To recent low | 0.3% | Market Cap | $136.097b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |